Share your opinion about this

3
Comment
Favorite

Ponytail
2025-10-30

Share your opinion about this news…

Novo Nordisk Said to Make Higher Bid for Metsera to Challenge Pfizer, Bloomberg News Reports

Novo has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications.

Novo Nordisk Said to Make Higher Bid for Metsera to Challenge Pfizer, Bloomberg News Reports

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":494789715079416,"tweetId":"494789715079416","gmtCreate":1761816037454,"gmtModify":1761816367627,"author":{"id":4224005262086462,"idStr":"4224005262086462","authorId":4224005262086462,"authorIdStr":"4224005262086462","name":"Ponytail","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>Share your opinion about this news…</p></body></html>","htmlText":"<html><head></head><body><p>Share your opinion about this news…</p></body></html>","text":"Share your opinion about this news…","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/494789715079416","repostId":1173836901,"repostType":2,"repost":{"id":"1173836901","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1761815941,"share":"https://ttm.financial/m/news/1173836901?lang=en_US&edition=fundamental","pubTime":"2025-10-30 17:19","market":"us","language":"en","title":"Novo Nordisk Said to Make Higher Bid for Metsera to Challenge Pfizer, Bloomberg News Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=1173836901","media":"Reuters","summary":"Novo has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications.","content":"<html><head></head><body><p>Oct 30 (Reuters) - Danish drugmaker <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> has made a higher offer for <a href=\"https://laohu8.com/S/MTSR\">Metsera</a> seeking to trump an agreed deal with <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.</p><p>Novo Nordisk, which had earlier made a takeover proposal for Metsera before the US company reached a deal with Pfizer, has come back with another offer with an improved value and structure, the people said. Metsera and Novo Nordisk are in advanced discussions on the sweetened bid and could reach an agreement on a potential deal as soon as Thursday, the people said.</p><p>Metsera shares jumped 18.6% in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/846bb5a38e33734b0ac200f5983840db\" title=\"\" tg-width=\"535\" tg-height=\"159\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk Said to Make Higher Bid for Metsera to Challenge Pfizer, Bloomberg News Reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk Said to Make Higher Bid for Metsera to Challenge Pfizer, Bloomberg News Reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-30 17:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Oct 30 (Reuters) - Danish drugmaker <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> has made a higher offer for <a href=\"https://laohu8.com/S/MTSR\">Metsera</a> seeking to trump an agreed deal with <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.</p><p>Novo Nordisk, which had earlier made a takeover proposal for Metsera before the US company reached a deal with Pfizer, has come back with another offer with an improved value and structure, the people said. Metsera and Novo Nordisk are in advanced discussions on the sweetened bid and could reach an agreement on a potential deal as soon as Thursday, the people said.</p><p>Metsera shares jumped 18.6% in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/846bb5a38e33734b0ac200f5983840db\" title=\"\" tg-width=\"535\" tg-height=\"159\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MTSR":"Metsera Inc.","NVO":"诺和诺德"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173836901","content_text":"Oct 30 (Reuters) - Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.Novo Nordisk, which had earlier made a takeover proposal for Metsera before the US company reached a deal with Pfizer, has come back with another offer with an improved value and structure, the people said. Metsera and Novo Nordisk are in advanced discussions on the sweetened bid and could reach an agreement on a potential deal as soon as Thursday, the people said.Metsera shares jumped 18.6% in premarket trading.","news_type":1,"symbols_score_info":{"NVO":1.1,"MTSR":1.1}},"isVote":1,"tweetType":1,"viewCount":41,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":30,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}